Opinion
Video
Author(s):
The panel discusses data on the accuracy of MRI-targeted or fusion-based biopsy procedures compared with systemic biopsy or MRI alone.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Telehealth in urologic cancer: Lessons learned from the COVID-19 pandemic
Pearls & Perspectives: Helen Bernie, DO, MPH, at AUA 2025
Phase 2 trial launches of (177Lu) rhPSMA-10.1 injection in mCRPC
Dr. Murphy on increasing diversity in cancer clinical trials
Ultra-low PSA responses are more prevalent with darolutamide plus ADT
ARANOTE substudy highlights benefits of darolutamide in Black men
Real-time IRP monitoring may redefine safety and scope of flexible ureteroscopy
Published data support safety, efficacy of vaginal insert for SUI
Enrollment progresses in study for cisplatin-induced hearing loss in testicular cancer